| Trial ID: | L3011 |
| Source ID: | NCT00349986
|
| Associated Drug: |
Insuline Glargine
|
| Title: |
LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Insuline glargine
|
| Outcome Measures: |
Primary: HgbA1c measurement |
|
| Sponsor/Collaborators: |
Sponsor: Sanofi
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
4
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-09
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2009-12-07
|
| Locations: |
Sanofi-Aventis, Budapest, Hungary
|
| URL: |
https://clinicaltrials.gov/show/NCT00349986
|
